Orange Book product · Generic (ANDA)
OGEN .625
ESTROPIPATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ESTROPIPATE
Strength
0.75MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 083220
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ESTROPIPATE
- 1999ESTROPIPATEGeneric (ANDA)
ANDA 040296 · DURAMED PHARMS BARR
- 1999ESTROPIPATEGeneric (ANDA)
ANDA 040359 · PHARMOBEDIENT
- 1996ESTROPIPATEGeneric (ANDA)
ANDA 040135 · BARR
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081213 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081214 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081216 · WATSON LABS
- 1993ESTROPIPATEGeneric (ANDA)
ANDA 081215 · WATSON LABS TEVA
- 1991ORTHO-ESTGeneric (ANDA)
ANDA 089582 · SUN PHARM INDS INC
- 1991ORTHO-ESTGeneric (ANDA)
ANDA 089567 · SUN PHARM INDS INC
- —OGENGeneric (ANDA)
ANDA 084710 · PHARMACIA AND UPJOHN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
